Nicotinic Acid Hydrazide

Nicotinic Acid Hydrazide

SCHEMBL29648965

NNC(=O)c1cccnc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.69
HDAC6 Q9UBN7 1/20 0.69
THRB P10828 1/20 0.68
LMNA P02545 1/20 0.62
HIF1A Q16665 1/20 0.62
F7 P08709 1/20 0.62
F3 P13726 1/20 0.62
SARM1 Q6SZW1 1/20 0.62
SIRT2 Q8IXJ6 1/20 0.62
SIRT6 Q8N6T7 1/20 0.62
SIRT1 Q96EB6 1/20 0.62
SIRT3 Q9NTG7 1/20 0.62
SIRT5 Q9NXA8 1/20 0.62
SIRT4 Q9Y6E7 1/20 0.62
ROCK2 O75116 1/20 0.61
ROCK1 Q13464 1/20 0.61
PLOD2 O00469 1/20 0.59
ALDH1A1 P00352 3/20 0.59
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nicotinic Acid Hydrazide SCHEMBL258390 1.00 HDAC1 (0.69) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28747918 0.98 HDAC1 (0.67) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL31491467 0.98 HDAC1 (0.67) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28127107 0.94 HDAC1 (0.62) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28112815 0.91 HDAC1 (0.59) HDAC1HDAC6THRBLMNAHIF1A
Benzoic Acid Hydrazide SCHEMBL5778873 0.88 GAA (0.70) HDAC1HDAC6THRBF7F3
SCHEMBL2833544 0.87 ROCK2 (0.69) HDAC1HDAC6LMNAHIF1AROCK2
Nicotinic Acid Hydrazide SCHEMBL28304573 0.86 NAPRT (0.61) HDAC1HDAC6THRBLMNAPLOD2
SCHEMBL1019295 0.85 HDAC1 (0.65) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28304575 0.84 HCAR2 (0.57) HDAC1HDAC6THRBLMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874681-A Indole derivative, preparation method thereof and application of indole derivative in resisting liver cancer 中国人民解放军北部战区总医院 2025-04-25 CN claimed
EP-4673444-A1 OXADIAZOLE DERIVATIVE COMPOUNDS, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2026-01-07 EP disclosed
CN-115850241-B Substituted heterocyclic compound containing alpha-ketone skeleton and application thereof 中国药科大学 2025-01-14 CN disclosed
WO-2024180464-A1 OXADIAZOLE DERIVATIVE COMPOUNDS, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2024-09-06 WO disclosed
CN-118464808-A Method for detecting fluorine ions and application thereof 华南师范大学 2024-08-09 CN disclosed
CN-114174292-B Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors 修复治疗公司 2024-06-18 CN disclosed
CN-111527084-B Isofuranone compounds useful as HPK1 inhibitors 百时美施贵宝公司 2023-07-18 CN disclosed
CN-115850241-A Substituted heterocyclic compound containing alpha-ketone skeleton and application thereof 中国药科大学 2023-03-28 CN disclosed
EP-4013508-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES Bayer Aktiengesellschaft (DE) 2022-06-22 EP disclosed